PREDNISOLONE , PREDNISONE , -, Ifinatamab Deruxtecan, PARACETAMOL , -, DOCETAXEL , -, -, -
MK-2400-001
Phase 3 small_molecule active
Quick answer
PREDNISOLONE , PREDNISONE , -, Ifinatamab Deruxtecan, PARACETAMOL , -, DOCETAXEL , -, -, - for Metastatic Castration-Resistant Prostate Cancer is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Metastatic Castration-Resistant Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active